Loading…

De novo production of the flavonoid naringenin in engineered Saccharomyces cerevisiae

Flavonoids comprise a large family of secondary plant metabolic intermediates that exhibit a wide variety of antioxidant and human health-related properties. Plant production of flavonoids is limited by the low productivity and the complexity of the recovered flavonoids. Thus to overcome these limit...

Full description

Saved in:
Bibliographic Details
Published in:Microbial cell factories 2012-12, Vol.11 (1), p.155-155, Article 155
Main Authors: Koopman, Frank, Beekwilder, Jules, Crimi, Barbara, van Houwelingen, Adele, Hall, Robert D, Bosch, Dirk, van Maris, Antonius J A, Pronk, Jack T, Daran, Jean-Marc
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Flavonoids comprise a large family of secondary plant metabolic intermediates that exhibit a wide variety of antioxidant and human health-related properties. Plant production of flavonoids is limited by the low productivity and the complexity of the recovered flavonoids. Thus to overcome these limitations, metabolic engineering of specific pathway in microbial systems have been envisaged to produce high quantity of a single molecules. Saccharomyces cerevisiae was engineered to produce the key intermediate flavonoid, naringenin, solely from glucose. For this, specific naringenin biosynthesis genes from Arabidopsis thaliana were selected by comparative expression profiling and introduced in S. cerevisiae. The sole expression of these A. thaliana genes yielded low extracellular naringenin concentrations (
ISSN:1475-2859
1475-2859
DOI:10.1186/1475-2859-11-155